BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 28951401)

  • 1. Evolving landscape of stroke prevention in atrial fibrillation within the UK between 2012 and 2016: a cross-sectional analysis study using CPRD.
    Lacoin L; Lumley M; Ridha E; Pereira M; McDonald L; Ramagopalan S; Lefèvre C; Evans D; Halcox JP
    BMJ Open; 2017 Sep; 7(9):e015363. PubMed ID: 28951401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of anticoagulants in the management of atrial fibrillation among general practices in England.
    Cowan C; Healicon R; Robson I; Long WR; Barrett J; Fay M; Tyndall K; Gale CP
    Heart; 2013 Aug; 99(16):1166-72. PubMed ID: 23393083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk profiles and pattern of antithrombotic use in patients with non-valvular atrial fibrillation in Thailand: a multicenter study.
    Krittayaphong R; Winijkul A; Methavigul K; Wongtheptien W; Wongvipaporn C; Wisaratapong T; Kunjara-Na-Ayudhya R; Boonyaratvej S; Komoltri C; Kaewcomdee P; Yindeengam A; Sritara P;
    BMC Cardiovasc Disord; 2018 Aug; 18(1):174. PubMed ID: 30144802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discrepancy between guidelines for stroke prevention in atrial fibrillation and practice patterns in primary care. The nationwide French AFIGP survey.
    Sabouret P; Bricard M; Hermann MA; Cotté FE; Deret-Bixio L; Rushton-Smith S
    Arch Cardiovasc Dis; 2015 Nov; 108(11):544-53. PubMed ID: 26113478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment patterns in anticoagulant therapy in patients with newly diagnosed atrial fibrillation in Belgium: results from the GARFIELD-AF registry.
    Cools F; Wollaert B; Vervoort G; Verstraete S; Voet J; Hermans K; Heyse A; De Wolf A; Hollanders G; Boussy T; Anné W; Vercammen J; Faes D; Beutels M; Mairesse G; Purnode P; Blankoff I; Vandergoten P; Capiau L; Allu J; Bassand JP; Kayani G;
    Acta Cardiol; 2019 Aug; 74(4):309-318. PubMed ID: 30369290
    [No Abstract]   [Full Text] [Related]  

  • 6. Temporal trends in antithrombotic treatment of real-world UK patients with newly diagnosed atrial fibrillation: findings from the GARFIELD-AF registry.
    Apenteng PN; Gao H; Hobbs FR; Fitzmaurice DA;
    BMJ Open; 2018 Jan; 8(1):e018905. PubMed ID: 29331969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term vitamin K antagonists treatment patterns of Non-Valvular Atrial Fibrillation (NVAF): a population-based cohort study.
    Renoux C; Coulombe J; Suissa S
    BMC Cardiovasc Disord; 2016 May; 16():84. PubMed ID: 27160254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimising stroke prevention in patients with atrial fibrillation: application of the GRASP-AF audit tool in a UK general practice cohort.
    Shantsila E; Wolff A; Lip GY; Lane DA
    Br J Gen Pract; 2015 Jan; 65(630):e16-23. PubMed ID: 25548312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Adherence to Guideline-Directed Antithrombotic Therapy for Atrial Fibrillation at Hospital Discharge.
    Dupree L; DeLosSantos M; Smotherman C
    J Cardiovasc Pharmacol Ther; 2018 Nov; 23(6):502-508. PubMed ID: 29806486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation.
    Camm AJ; Accetta G; Ambrosio G; Atar D; Bassand JP; Berge E; Cools F; Fitzmaurice DA; Goldhaber SZ; Goto S; Haas S; Kayani G; Koretsune Y; Mantovani LG; Misselwitz F; Oh S; Turpie AG; Verheugt FW; Kakkar AK;
    Heart; 2017 Feb; 103(4):307-314. PubMed ID: 27647168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Tasmanian atrial fibrillation study: Transition to direct oral anticoagulants 2011-2015.
    Alamneh EA; Chalmers L; Bereznicki LR
    Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28177198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombotic therapy in elderly patients with non-valvular atrial fibrillation: a pilot study.
    Xiang W; Zhang J; Liu M; Liu F; Feng X; Wang Y
    Clin Interv Aging; 2015; 10():515-9. PubMed ID: 25767378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of advanced age on management and prognosis in atrial fibrillation: insights from a population-based study in general practice.
    Wolff A; Shantsila E; Lip GY; Lane DA
    Age Ageing; 2015 Sep; 44(5):874-8. PubMed ID: 26082176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of suboptimal anticoagulation treatment with antiplatelet therapy and warfarin on clinical outcomes in patients with nonvalvular atrial fibrillation: A population-wide cohort study.
    Chan EW; Lau WC; Siu CW; Lip GY; Leung WK; Anand S; Man KK; Wong IC
    Heart Rhythm; 2016 Aug; 13(8):1581-8. PubMed ID: 27033342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombotic prophylaxis of atrial fibrillation in an Italian real-world setting: a retrospective study.
    Ermini G; Perrone V; Veronesi C; Degli Esposti L; Di Pasquale G
    Vasc Health Risk Manag; 2017; 13():239-246. PubMed ID: 28740396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.
    Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Ioachim PM; Tica O; Boriani G; Cimaglia P; Diemberger I; Hellum CF; Mortensen B; Maggioni AP
    Am J Med; 2014 Jun; 127(6):519-29.e1. PubMed ID: 24486284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rates and Determinants for the Use of Anticoagulation Treatment before Stroke in Patients with Known Atrial Fibrillation.
    Giustozzi M; Agnelli G; Quattrocchi S; Acciarresi M; Alberti A; Caso V; Vedovati MC; Venti M; Paciaroni M
    Cerebrovasc Dis Extra; 2020; 10(2):44-49. PubMed ID: 32375143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticoagulant Use in Patients With Nonvalvular Atrial Fibrillation: Has Prescribing Improved?
    Bista D; Chalmers L; Peterson GM; Bereznicki LRE
    Clin Appl Thromb Hemost; 2017 Sep; 23(6):573-578. PubMed ID: 27071408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of Trends in Guideline-Based Oral Anticoagulant Prescription for Patients With Ischemic Stroke and Atrial Fibrillation in China.
    Gu HQ; Yang X; Wang CJ; Zhao XQ; Wang YL; Liu LP; Meng X; Jiang Y; Li H; Liu C; Xiong YY; Fonarow GC; Wang D; Xian Y; Li ZX; Wang YJ
    JAMA Netw Open; 2021 Jul; 4(7):e2118816. PubMed ID: 34323982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stroke Risk Status, Anticoagulation Treatment, and Quality-of-Life in Chinese Patients with Atrial Fibrillation: China Registry of Atrial Fibrillation (CRAF).
    Sun Y; Zhu J; Ma C; Liu S; Yang Y; Hu D
    Cardiovasc Ther; 2019; 2019():7372129. PubMed ID: 31772614
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.